Deutsche Bank’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History
Bought
Maintained
Sold
Other funds holding XPH
CI
FCBT
Deutsche Bank's XPH Position: Q4 2023 in Review
Deutsche Bank sold out of State Street SPDR S&P Pharmaceuticals ETF (XPH) in Q4 2023, closing a stake of 290 shares — an estimated $11.5K sold.
Deutsche Bank first reported a position in XPH in Q2 2013 and held it in 18 quarters. The position peaked at $25.8M in Q2 2018. 73 funds tracked by Wall St. Rank hold XPH as of Q4 2023.
- Deutsche Bank reported no remaining State Street SPDR S&P Pharmaceuticals ETF position as of Q4 2023 after selling out during the quarter.
- Deutsche Bank sold 290 State Street SPDR S&P Pharmaceuticals ETF shares in Q4 2023, an estimated $11.5K.
- Deutsche Bank first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q2 2013 and held it in 18 quarters.
- Deutsche Bank's State Street SPDR S&P Pharmaceuticals ETF position peaked at $25.8M in Q2 2018.
- 73 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q4 2023.
Based on Deutsche Bank's 13F filing for Q4 2023, filed 14 Feb 2024.